Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30.06.2026, reporting a net loss of Rs. (132.71) Lakhs compared to a loss of Rs. (148.01) Lakhs in the corresponding quarter of the previous year. The revenue from operations for the current quarter is Nil compared to Rs. 151.88 Lakhs for the corresponding quarter of the previous year.

Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30.06.2026, reporting a net loss of Rs. (98.59) lakhs compared to a loss of Rs. (129.04) lakhs in the corresponding quarter of the previous year. The revenue from operations for the current quarter is Nil compared to Rs. 151.88 lakhs for the corresponding quarter of the previous year. The company has also issued 10,243,998 Convertible Share Warrants and received 25% of the upfront subscription amounting to INR 307.50 lakhs.

Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve unaudited financial results for the quarter ended 30.06.2026.